Endothelin type A receptors mediate pain in a mouse model of sickle cell disease.

MedStar author(s):
Citation: Haematologica. 103(7):1124-1135, 2018 07.PMID: 29545351Institution: MedStar Southern Maryland Hospital CenterDepartment: Intensive Care UnitForm of publication: Journal ArticleMedline article type(s): Journal Article | Research Support, N.I.H., ExtramuralSubject headings: *Anemia, Sickle Cell/co [Complications] | *Anemia, Sickle Cell/ge [Genetics] | *Pain/et [Etiology] | *Receptor, Endothelin A/ge [Genetics] | Anemia, Sickle Cell/me [Metabolism] | Animals | Biomarkers | Disease Models, Animal | Disease Susceptibility | Endothelin-1/me [Metabolism] | Ganglia, Spinal/cy [Cytology] | Ganglia, Spinal/me [Metabolism] | Ganglia, Spinal/pp [Physiopathology] | Hyperalgesia/di [Diagnosis] | Hyperalgesia/ge [Genetics] | Hyperalgesia/me [Metabolism] | Male | Mice | Mice, Knockout | Mice, Transgenic | Pain/di [Diagnosis] | Pain/me [Metabolism] | Posterior Horn Cells/me [Metabolism] | Receptor, Endothelin A/me [Metabolism]Year: 2018ISSN:
  • 0390-6078
Name of journal: HaematologicaAbstract: Copyright(c) 2018 Ferrata Storti Foundation.Sickle cell disease is associated with acute painful episodes and chronic intractable pain. Endothelin-1, a known pain inducer, is elevated in the blood plasma of both sickle cell patients and mouse models of sickle cell disease. We show here that the levels of endothelin-1 and its endothelin type A receptor are increased in the dorsal root ganglia of a mouse model of sickle cell disease. Pharmacologic inhibition or neuron-specific knockdown of endothelin type A receptors in primary sensory neurons of dorsal root ganglia alleviated basal and post-hypoxia evoked pain hypersensitivities in sickle cell mice. Mechanistically, endothelin type A receptors contribute to sickle cell disease-associated pain likely through the activation of NF-kappaB-induced Nav1.8 channel upregulation in primary sensory neurons of sickle cell mice. Our findings suggest that endothelin type A receptor is a potential target for the management of sickle cell disease-associated pain, although this expectation needs to be further verified in clinical settings.All authors: Atianjoh FE, Fox BM, Gu X, Li Z, Lutz BM, Pollock DM, Tao YX, Wu SFiscal year: FY2019Digital Object Identifier: Date added to catalog: 2018-04-20
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 29545351 Available 29545351

Copyright(c) 2018 Ferrata Storti Foundation.

Sickle cell disease is associated with acute painful episodes and chronic intractable pain. Endothelin-1, a known pain inducer, is elevated in the blood plasma of both sickle cell patients and mouse models of sickle cell disease. We show here that the levels of endothelin-1 and its endothelin type A receptor are increased in the dorsal root ganglia of a mouse model of sickle cell disease. Pharmacologic inhibition or neuron-specific knockdown of endothelin type A receptors in primary sensory neurons of dorsal root ganglia alleviated basal and post-hypoxia evoked pain hypersensitivities in sickle cell mice. Mechanistically, endothelin type A receptors contribute to sickle cell disease-associated pain likely through the activation of NF-kappaB-induced Nav1.8 channel upregulation in primary sensory neurons of sickle cell mice. Our findings suggest that endothelin type A receptor is a potential target for the management of sickle cell disease-associated pain, although this expectation needs to be further verified in clinical settings.

English

Powered by Koha